28 results
8-K
RGPX
Regenerex Pharma, Inc.
19 Nov 21
Departure of Directors or Certain Officers
2:48pm
aspect of Woundcare from FDA and CE compliance reimbursement, manufacturing and distribution. Mr. Pilant was one the of first fifteen voted
PRE 14C
RGPX
Regenerex Pharma, Inc.
23 Nov 21
Preliminary information
3:51pm
for their time spent on behalf of the Company, but they are entitled to receive reimbursement for all out-of-pocket expenses incurred for attending Board … to receive reimbursement for all out of pocket expenses incurred for attendance at our Board of Directors meetings.
Stock Option Grants
We did not grant any
DEF 14C
RGPX
Regenerex Pharma, Inc.
22 Dec 21
Information statement
5:07pm
of Directors
The Company does not compensate its directors for their time spent on behalf of the Company, but they are entitled to receive reimbursement … for their time spent on behalf of our Company, but they are entitled to receive reimbursement for all out of pocket expenses incurred for attendance
PRE 14C
RGPX
Regenerex Pharma, Inc.
26 Aug 11
Preliminary information
12:00am
of our
Company, but they are entitled to receive reimbursement for all out of pocket
expenses incurred for attendance at our Board of Directors meetings
PRE 14C
RGPX
Regenerex Pharma, Inc.
25 Jun 10
Preliminary information
12:00am
for their time spent on behalf of
our Company, but they are entitled to receive reimbursement for all out of
pocket expenses incurred
DEF 14C
6zoet34brjpez4
7 Jul 10
Information statement
12:00am
PRER14C
cl9z2
6 Jul 10
Preliminary revised information
12:00am
CORRESP
dbjweapq20y7vt
2 Jul 10
Correspondence with SEC
12:00am
10-12G/A
blbpn5bce6hcyx4
18 Aug 17
Registration of securities (amended)
12:00am
10-12G/A
3xobm kmoo81dz4a
6 Sep 17
Registration of securities (amended)
12:00am